beta-lactams has been researched along with raltegravir potassium in 1 studies
| Studies (beta-lactams) | Trials (beta-lactams) | Recent Studies (post-2010) (beta-lactams) | Studies (raltegravir potassium) | Trials (raltegravir potassium) | Recent Studies (post-2010) (raltegravir potassium) |
|---|---|---|---|---|---|
| 7,579 | 179 | 3,395 | 1,238 | 243 | 879 |
| Protein | Taxonomy | beta-lactams (IC50) | raltegravir potassium (IC50) |
|---|---|---|---|
| Translocator protein | Rattus norvegicus (Norway rat) | 0.13 | |
| Integrase | Human immunodeficiency virus 1 | 0.0494 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alves, AJS; Alves, N; Barahona, I; Bártolo, I; Borrego, P; Caixas, U; Diniz, AR; Figueiredo, I; Gomes, P; Gonçalves, F; Gonçalves, P; Martin, F; Moranguinho, I; Pinho E Melo, TMVD; Pinto, IV; Taveira, N | 1 |
1 other study(ies) available for beta-lactams and raltegravir potassium
| Article | Year |
|---|---|
High Instantaneous Inhibitory Potential of Bictegravir and the New Spiro-β-Lactam BSS-730A for HIV-2 Isolates from RAL-Naïve and RAL-Failing Patients.
Topics: Anti-HIV Agents; beta-Lactams; Drug Resistance, Viral; Heterocyclic Compounds, 4 or More Rings; HIV Infections; HIV Integrase Inhibitors; HIV-1; HIV-2; Humans; Raltegravir Potassium | 2022 |